Iberin for Health & Longevity - Quick Reference Sheet

Iberin for Health & Longevity

Created on 08/28/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5 – Audit

Iberin is a reactive sulfur compound released when cabbage-family vegetables are cut or chewed. Like its close relative sulforaphane, it switches on the cell's own protective and waste-clearing programs. What is known comes almost entirely from cells in culture and a handful of animal experiments. Nothing has been tested against a health outcome in a person. (Full Review)

Protocol

The whole-food alternative
3-5 servings daily
Raw or lightly steamed cruciferous vegetables, with horseradish or mustard as concentrated additions.
The Johns Hopkins broccoli sprout approach
25-100 µmol every 8 hours
Standardized sprout extracts dosed by glucosinolate or isothiocyanate content; the phase I protocol ran seven days.
Split versus single dosing
Split across meals
The only regimen with human pharmacokinetic support; a single dose leaves most of the day without measurable exposure.
Time to effect
Systemic exposure
Within 1 hour
Plasma isothiocyanate peaks within one hour and falls with a half-life near 1.8 hours, so no accumulation occurs between doses.
Enzyme induction
Hours to days
Measurable within hours and plateaus within days.
Clinical benefit
Not stated
No clinical outcome has ever been observed, so no meaningful time-to-benefit can be stated for iberin at all.

Benefits

Contraindications
  • Anyone considering isolated iberin from a chemical supplier
  • Pregnant and breastfeeding women
  • Untreated or poorly controlled hypothyroidism (thyroid-stimulating hormone above 10 mIU/L) or documented iodine intake below 100 µg/day
  • Active peptic ulceration or erosive esophagitis (Los Angeles grade C or D)
  • Advanced chronic kidney disease (estimated glomerular filtration rate below 30 mL/min/1.73 m²)
Key Interactions
  • Thiol-containing supplements (N-acetylcysteine, glutathione, alpha-lipoic acid)
  • Selenium
  • Other isothiocyanates (sulforaphane, erucin, alyssin, iberverin)
  • Vitamin K antagonists (warfarin, acenocoumarol, phenprocoumon)
  • Thyroid hormone replacement (levothyroxine, liothyronine)
  • Acetaminophen and other glutathione-depleting agents
  • Over-the-counter proton pump inhibitors and antacids (omeprazole, calcium carbonate)
  • Fasting and ketogenic protocols

Risk & Side Effects

  • Low: Gastrointestinal and oropharyngeal irritation; thyroid function disruption
  • Speculative: Cytotoxicity and oxidative stress in non-malignant cells; DNA damage response and necrosis above the cytotoxic threshold; altered handling of co-administered medications; mucosal and airway irritation from concentrated preparations

Monitoring

Marker Target Why
TSH 0.5-2.0 mIU/L Detects the thyroid suppression that is the main theoretical hazard
Free T4 1.0-1.5 ng/dL Confirms actual hormone output when TSH shifts
TPO antibodies Negative, below 9 IU/mL Identifies pre-existing autoimmune thyroid disease before loading begins
hs-CRP Below 0.5 mg/L Tracks the systemic inflammation the intervention is proposed to lower
GGT Below 20 U/L Proxy for glutathione turnover, which iberin consumes and induces
ALT Below 20 U/L in men, below 17 U/L in women Detects liver-cell stress from any concentrated extract
eGFR Above 90 mL/min/1.73 m² Clearance of iberin conjugates depends on renal tubular secretion
Urinary isothiocyanate conjugates No established target exists; track the change from the individual's own pre-intervention baseline Verifies that dietary intake is actually producing systemic exposure

Cadence: Baseline panel before starting a sustained high-cruciferous protocol; thyroid panel repeated at 12 weeks, then at 6 and 12 months; inflammatory, liver and kidney markers every 6 to 12 months thereafter. TPO antibodies once at baseline unless the thyroid panel shifts.

Qualitative Assessment

  • Upper gastrointestinal comfort, specifically burning, reflux or nausea following cruciferous-heavy meals
  • Bloating and flatulence, which rise with cruciferous fiber independently of iberin and are the commonest reason protocols are abandoned
  • Cold intolerance, unexplained fatigue or dry skin, the earliest subjective signs of falling thyroid output
  • Energy levels and cognitive clarity through the day, as the non-specific markers most often reported to change
  • Sleep quality, tracked to confirm the absence of the interaction that mechanism predicts should not occur